Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
10X Capital Venture Acquisitio - SIC # 6726 - UNIT INVESTMENT TRUSTS, FACE-AMOUNT CERTIFICATE OFFICES, AND CLOS
Ticker
Exchange
SIC #
Website
Latest Ticker
VCXB
American
6726
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for 10X Capital Venture Acquisitio
10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-K Filing
- Apr 23rd, 2024 8:42 pm
10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Noncompliance
- Jan 31st, 2024 10:16 pm
10X Capital Venture Acquisition Corp. III Announces Expected Change in Management
- Jan 8th, 2024 11:00 am
10X Capital Venture Acquisition Corp. III Announces Transfer of Listed Securities to the NYSE American
- Oct 4th, 2023 10:07 pm
Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III
- Aug 10th, 2023 1:07 am
Addimmune, a Clinical Stage Hiv-Focused Gene Therapy Company, to go Public Through Business Combination With 10x Capital Venture Acquisition Corp. III
- Aug 9th, 2023 11:02 pm
Scroll